Histogenics Corporation Announces Proposed Public Offering of Common Stock and Warrants

Go back to Histogenics Corporation Announces Proposed Public Offering of Common Stock and Warrants

Histogenics (HSGX) Prices Public Offering of Common Stock, Warrants

October 5, 2018 8:11 AM EDT

Histogenics Corporation (Histogenics) (Nasdaq: HSGX), a leader in the development of restorative cell therapies, today announced the pricing of an underwritten public offering of 26,155,000 shares of its common stock and warrants to purchase up to 19,616,250 shares of common stock, at a combined purchase price of $0.65 per share of common stock and accompanying warrant. The gross proceeds to Histogenics from this offering are... More